RUSSO, EDDA
 Distribuzione geografica
Continente #
EU - Europa 2.738
NA - Nord America 2.601
AS - Asia 703
AF - Africa 19
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.069
Nazione #
US - Stati Uniti d'America 2.587
RU - Federazione Russa 1.031
PL - Polonia 738
IT - Italia 431
IE - Irlanda 219
HK - Hong Kong 190
SG - Singapore 189
SE - Svezia 166
CN - Cina 147
IN - India 64
JO - Giordania 54
DE - Germania 32
FI - Finlandia 31
VN - Vietnam 29
GB - Regno Unito 20
CH - Svizzera 16
FR - Francia 15
CA - Canada 12
NL - Olanda 11
CI - Costa d'Avorio 9
ES - Italia 9
KR - Corea 9
TR - Turchia 7
IL - Israele 5
JP - Giappone 5
UA - Ucraina 5
UG - Uganda 5
EG - Egitto 4
AT - Austria 3
AU - Australia 3
BE - Belgio 3
CZ - Repubblica Ceca 3
RO - Romania 3
BR - Brasile 2
MX - Messico 2
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 6.069
Città #
Santa Clara 795
Warsaw 736
Chandler 217
Dublin 214
Fairfield 171
Singapore 162
Ashburn 141
Hong Kong 132
Florence 95
Seattle 94
Woodbridge 80
Houston 79
New York 78
Wilmington 68
Cambridge 55
Lawrence 51
Altamura 48
Beijing 42
Princeton 39
Moscow 35
Mumbai 35
Ann Arbor 31
Fiesole 30
Boston 28
Shanghai 28
Dong Ket 25
Pune 25
Buffalo 22
San Diego 18
Kent 16
Medford 16
Milan 16
West Jordan 16
Boardman 15
Rome 14
Bern 13
Helsinki 13
Hillsboro 11
Munich 10
Abidjan 9
Falls Church 9
London 9
Yubileyny 9
Toronto 8
Seoul 7
Catania 6
Lappeenranta 6
Norwalk 6
Castelliri 5
Izmir 5
Jacksonville 5
Kampala 5
Los Angeles 5
Phoenix 5
Redwood City 5
Tianjin 5
Washington 5
Andover 4
Bagno a Ripoli 4
Barcelona 4
Cairo 4
Prato 4
Romainville 4
San Francisco 4
Bari 3
Bologna 3
Bremen 3
Brno 3
Buccinasco 3
Bucharest 3
Cormons 3
Dearborn 3
Fuzhou 3
Menlo Park 3
Paris 3
Scarperia e San Piero 3
Shenzhen 3
St Petersburg 3
Takasago 3
Tel Aviv 3
Turin 3
Adelfia 2
Agliana 2
Amsterdam 2
Arezzo 2
Aversa 2
Brugherio 2
Brussels 2
Calenzano 2
Cartama 2
Cesena 2
Chiswick 2
Cincinnati 2
Gainesville 2
Gazzo 2
Gothenburg 2
Greve in Chianti 2
Guangzhou 2
Guelph 2
Hangzhou 2
Totale 3.945
Nome #
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 281
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 280
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 190
null 181
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 171
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 157
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 155
Evaluation and comparison of short chain fatty acids composition in gut diseases 153
Multiplex gene expression profile in inflamed mucosa of patients with Crohn’s disease ileal localization: A pilot study 152
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 147
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 123
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 120
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 117
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 117
Exploring the food-gut axis in immunotherapy response of cancer patients 114
Role of diet and gut microbiota on Colorectal cancer immunomodulation 111
The interplay between the microbiome and the adaptive immune response in cancer development 109
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 105
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 104
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 101
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 100
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 86
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 86
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 84
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 81
Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients 78
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 78
A two-stage strategy for early and accurate detection of B. cepacia in routine clinical analysis involving CF patients. Identification of Burkholderia cepacia strains by LAMP and SNuPE 77
Identification of Burkholderia cepacia complex species by LAMP or SNuPE analysis of his genes 75
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 74
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 73
LYSOZYME INTERACTION WITH NEGATIVELY CHARGED LIPID BILAYERS: PROTEIN AGGREGATION AND MEMBRANE FUSION 71
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study 70
Circulating Calprotectin (cCLP) in autoimmune diseases 67
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 67
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 66
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 66
Involvement of MIR-126 and MMP9 in the Pathogenesis of Intra-Abdominal Fistulizing Crohn’s Disease: A Brief Research Report 66
Thyroidectomy for cancer: The surgeon and the parathyroid glands sparing 66
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 65
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 65
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 64
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 63
JAK inhibitors and autoimmune rheumatic diseases. 63
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 62
Structural, functional and evolutionary analysis of histidine biosynthetic genes in Burkholderia strains 61
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 60
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 59
Is the age at surgery in Crohn's disease clinically relevant? Differences and peculiarities: a wide single centre experience after long-term follow-up 59
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 57
Crohn's disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors 56
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 55
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases 54
Surgery for Sporadic Primary Hyperparathyroidism: Evolution over the Last Twenty Years in a Monocentric Setting 51
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 50
Effects of the learning curve on operative time and lymph node harvesting during robotic gastrectomy 49
Identification of Burkholderia cepacia complex species by Loop Mediated Isothermal Amplification (LAMP) or Single Nucleotide Primer Extension (SNuPE) analysis of his genes 49
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 48
Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control 48
Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study 47
Inadequate food literacy is related to the worst health status and limitations in daily life in subjects with inflammatory bowel disease 46
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma 45
On the origin and evolution of operons: the piece-wise assembly of histidine biosynthetic genes in proteobacteria 45
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease 43
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 43
Microbiota and viral hepatitis: State of the art of a complex matter 42
Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) 40
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 38
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 35
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 34
Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1 32
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 31
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 30
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 29
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective 28
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 8
null 2
Totale 6.175
Categoria #
all - tutte 22.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 73 69 65 77 64 48 77 9
2020/2021568 42 50 42 72 33 50 32 39 53 92 26 37
2021/2022283 10 10 16 17 7 18 10 31 20 10 53 81
2022/20231.116 69 175 30 72 80 174 141 67 122 42 79 65
2023/2024826 27 46 89 44 62 164 35 166 12 60 65 56
2024/20252.403 127 388 237 632 1.019 0 0 0 0 0 0 0
Totale 6.175